Evaluation of peripheral blood involvement of mantle cell lymphoma by fluorescence in situ hybridization in comparison with immunophenotypic and morphologic findings.
Mantle cell lymphoma is non-Hodgkin's B-cell lymphoma characterized by the t(11;14)(q13;q32) translocation. Peripheral blood involvement of mantle cell lymphoma is usually associated with a poor prognosis and therefore, its identification is clinically important. In this study, we performed cyclin D1/IgH-probe fusion fluorescence in situ hybridization analysis on 223 peripheral blood samples: 185 from 125 mantle cell lymphoma patients, and 38 normal controls. The cutoff values for the test were established using normal controls. Flow cytometry on peripheral blood and corresponding bone marrow samples was used to evaluate this test. In all, 26% of the 185 peripheral blood samples and 27% of the 161 corresponding bone marrow samples were flow cytometry positive for mantle cell lymphoma. The mean numbers of single and- double-fusion signals and the mean number of CD5/CD19-positive cells, absolute blood lymphocyte count, and white blood cell count were significantly higher in peripheral blood and corresponding bone marrow samples with mantle cell lymphoma-positive flow cytometry. Double-fusion signals were more specific than single-fusion ones. Fluorescence in situ hybridization was far more likely to be positive for mantle cell lymphoma when the peripheral blood and the corresponding bone marrow samples had positive flow cytometry results or morphology (P<0.01). Our study indicates that cyclin D1/IgH-fusion fluorescence in situ hybridization analysis could be used to determine the presence and character of circulating mantle cell lymphoma cells in peripheral blood, thus enhancing our ability to evaluate leukemic mantle cell lymphoma and minimum residual disease.
Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Jun
J
Gu
Yang O
YO
Huh
Feng
F
Jiang
Nancy P
NP
Caraway
Jorge E
JE
Romaguera
Tanweer M
TM
Zaidi
Ricardo L
RL
Fernandez
Huazhong
H
Zhang
Issa F
IF
Khouri
Ruth L
RL
Katz
D018941:Antigens, CD19 / Q000032:analysis; D018956:CD5 Antigens / Q000032:analysis; D019938:Cyclin D1 / Q000235:genetics; D005434:Flow Cytometry / Q000379:methods; D007074:Immunoglobulin G / Q000235:genetics; D016130:Immunophenotyping / Q000379:methods*; D017404:In Situ Hybridization, Fluorescence / Q000379:methods*; D008214:Lymphocytes / Q000276:immunology / Q000378:metabolism / Q000473:pathology*; D020522:Lymphoma, Mantle-Cell / Q000097:blood* / Q000235:genetics / Q000473:pathology; D015203:Reproducibility of Results
D018941:Antigens, CD19; D018956:CD5 Antigens; D007074:Immunoglobulin G; D019938:Cyclin D1